1276 Fulton Avenue, Bronx, NY, 10456 · (212) 588-7000
Beds
454
FY 2025
Star rating
1 of 5
Patient survey: 2 of 5
Net patient revenue
$946.0M
FY 2025
Net income
$9.5M
Patient care margin -6.2%
Discharges
24,142
Occupancy 78.6%
Clinicians
340
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $946.0M | $1.00B | -6.2% | $9.5M | 24,142 | $101.2M | 8.1% | 14.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart failure patients | 8.3% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 12% | US median 15.2% |
| Death rate for stroke patients | 10.3% | US median 11.6% |
| Readmission rate for COPD | 22.5% | US median 19.8% |
| Readmission rate after a heart attack | 16% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $986.0M | $988.4M | -0.2% | $54.8M | 23,905 | $86.3M | 8.8% | 13.8% |
| 2023 | $871.3M | $910.1M | -4.5% | $23.8M | 22,026 | $80.1M | 9.7% | 12.3% |
| 2022 | $870.4M | $843.9M | 3.0% | $87.1M | 22,813 | $65.8M | 8.4% | 11.4% |
| 2021 | $760.7M | $816.1M | -7.3% | $61.6M | 23,081 | $49.8M | 8.6% | 12.6% |
| 2020 | $680.5M | $786.6M | -15.6% | $25.4M | 22,186 | $65.2M | 10.4% | 14.0% |
| US median 14.4% |
| Readmission rate for heart failure | 27.5% | US median 21.3% |
| Readmission rate after hip or knee replacement | 6.1% | US median 5.8% |
| Readmission rate for pneumonia | 19.8% | US median 17.2% |
| Complications after hip or knee replacement | 4.4% | US median 4.1% |
| Serious complications (patient safety composite) | 0.89 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.52 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 1.63 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.48 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.93 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.09 | US median 0.40 · better |
| Doctors always communicated well | 75% | US median 79% |
| Nurses always communicated well | 69% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 49% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 54% | US median 72% |
| Room and bathroom always clean | 69% | US median 73% |
| Patients who would definitely recommend the hospital | 56% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 186 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 9% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 66% | US median 65% |
| Healthcare workers given the flu vaccine | 67% | US median 79% |
| 37 |
| $41,227.89 |
| $24,860.92 |
| $12,667.88 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 28 | $99,441.61 | $82,918.43 | $58,777.93 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 26 | $38,605.81 | $25,058.88 | $12,400.10 |
| DRG 974 HIV WITH MAJOR RELATED CONDITION WITH MCC | 22 | $70,800.82 | $43,934.05 | $38,449.62 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 21 | $33,821.29 | $21,481.19 | $9,867.73 |
| DRG 004 TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NECK WITHOU | 21 | $160,578.52 | $128,157.19 | $120,703.94 |
| DRG 894 ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA | 21 | $14,499.29 | $12,663.10 | $5,528.11 |
| DRG 300 PERIPHERAL VASCULAR DISORDERS WITH CC | 20 | $31,577.60 | $18,781.85 | $8,373.64 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 19 | $31,080.68 | $14,592.74 | $5,985.69 |
| DRG 917 POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC | 19 | $40,508.63 | $24,605.32 | $13,880.41 |
| DRG 057 DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC | 18 | $38,804.94 | $20,048.17 | $11,625.30 |
| DRG 884 ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | 18 | $44,394.83 | $24,197.39 | $13,593.39 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 17 | $30,236.47 | $15,695.00 | $5,662.18 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5372 Level 2 Urology and Related Services | 17 | 16 | $604.11 | $502.15 |
| APC 5165 Level 5 ENT Procedures | - | - | - | $4,436.36 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5191 Level 1 Endovascular Procedures | - | - | - | $2,207.96 |
| APC 5302 Level 2 Upper GI Procedures | - | - | - | $1,444.50 |
| APC 5313 Level 3 Lower GI Procedures | - | - | - | $2,176.09 |
| APC 5361 Level 1 Laparoscopy and Related Services | - | - | - | $4,357.80 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 5375 Level 5 Urology and Related Services | - | - | - | $3,917.51 |
| APC 5414 Level 4 Gynecologic Procedures | - | - | - | $2,389.24 |
| APC 5415 Level 5 Gynecologic Procedures | - | - | - | $3,792.42 |
| APC 5431 Level 1 Nerve Procedures | - | - | - | $1,406.61 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $89K |
| Cochlear Americas | 1 | $194 |
| Fisher Scientific Company L.L.C. | 1 | $186 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Bronxcare Hospital Center is a nonprofit short-term acute care hospital in Bronx, NY with 454 beds, part of BronxCare Health System and a 1-star overall rating.
Bronxcare Hospital Center in Bronx, NY has 454 beds (fiscal year 2025 cost report); 579 beds are certified for Medicare. It discharged 24,142 inpatients that year, with 78.6% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Bronxcare Hospital Center reported net patient revenue of $946.0M and operating expenses of $1.00B, a margin on patient care of -6.2%. After other income and expenses its net income was $9.5M (1.0% of revenue), so it made a profit that year.
Bronxcare Hospital Center is part of BronxCare Health System, a health system with 1 hospitals based in Bronx, NY. It is a nonprofit hospital.
Bronxcare Hospital Center has an overall rating of 1 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, Bronxcare Hospital Center provides emergency services.
340 Medicare clinicians list Bronxcare Hospital Center as a hospital they work at, most often in Emergency Medicine, Family Practice, Nurse Practitioner.
In 2024, Bronxcare Hospital Center had 824 Medicare inpatient stays in 40 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 145 stays; Medicare paid $29,494.14 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $90K in payments to Bronxcare Hospital Center as a teaching hospital ($90K general and - for research) from 3 companies.